https://fusion-live.leviathanstudiosltd.com/https://fusion-live.leviathanstudiosltd.com/about/https://fusion-live.leviathanstudiosltd.com/accessibility-statement/https://fusion-live.leviathanstudiosltd.com/applications/https://fusion-live.leviathanstudiosltd.com/applications/diagnostics/https://fusion-live.leviathanstudiosltd.com/applications/human-therapeutics/https://fusion-live.leviathanstudiosltd.com/applications/veterinary-medicine/https://fusion-live.leviathanstudiosltd.com/careers/https://fusion-live.leviathanstudiosltd.com/careers/business-development-manager/https://fusion-live.leviathanstudiosltd.com/careers/scientist-expression-purification/https://fusion-live.leviathanstudiosltd.com/careers/senior-scientist-antibody-discovery/https://fusion-live.leviathanstudiosltd.com/collaborations/amgen/https://fusion-live.leviathanstudiosltd.com/collaborations/bayer/https://fusion-live.leviathanstudiosltd.com/collaborations/beigene/https://fusion-live.leviathanstudiosltd.com/collaborations/harvard-university/https://fusion-live.leviathanstudiosltd.com/collaborations/johns-hopkins/https://fusion-live.leviathanstudiosltd.com/collaborations/mayo-clinic/https://fusion-live.leviathanstudiosltd.com/collaborations/merck/https://fusion-live.leviathanstudiosltd.com/collaborations/moderna/https://fusion-live.leviathanstudiosltd.com/collaborations/pfizer/https://fusion-live.leviathanstudiosltd.com/collaborations/queens-university-belfast/https://fusion-live.leviathanstudiosltd.com/collaborations/roche/https://fusion-live.leviathanstudiosltd.com/collaborations/sanofi/https://fusion-live.leviathanstudiosltd.com/contact/https://fusion-live.leviathanstudiosltd.com/cookie-policy/https://fusion-live.leviathanstudiosltd.com/disclaimer/https://fusion-live.leviathanstudiosltd.com/events/https://fusion-live.leviathanstudiosltd.com/events/17th-drug-discovery-innovation-programme/https://fusion-live.leviathanstudiosltd.com/events/aet-europe-2025/https://fusion-live.leviathanstudiosltd.com/events/anglo-nordic-conference-2023/https://fusion-live.leviathanstudiosltd.com/events/antibody-engineering-development-forum/https://fusion-live.leviathanstudiosltd.com/events/antibody-engineering-therapeutics-europe/https://fusion-live.leviathanstudiosltd.com/events/antibody-engineering-therapeutics-usa/https://fusion-live.leviathanstudiosltd.com/events/antibody-industrial-symposium-2022/https://fusion-live.leviathanstudiosltd.com/events/antibody-therapeutics-xchange/https://fusion-live.leviathanstudiosltd.com/events/bio-europe-spring-2023/https://fusion-live.leviathanstudiosltd.com/events/bio-integrates-2023/https://fusion-live.leviathanstudiosltd.com/events/bio-international-2023/https://fusion-live.leviathanstudiosltd.com/events/bio-international-convention-2025/https://fusion-live.leviathanstudiosltd.com/events/bio-international-convention/https://fusion-live.leviathanstudiosltd.com/events/bio-korea-2023/https://fusion-live.leviathanstudiosltd.com/events/discovery-on-target-2022/https://fusion-live.leviathanstudiosltd.com/events/discovery-on-target-2023/https://fusion-live.leviathanstudiosltd.com/events/drug-discovery-2022/https://fusion-live.leviathanstudiosltd.com/events/function-first-antibody-discovery/https://fusion-live.leviathanstudiosltd.com/events/fusion-partnering-day-belfast/https://fusion-live.leviathanstudiosltd.com/events/hubxchange-west-coast-xchange/https://fusion-live.leviathanstudiosltd.com/events/pegs-boston-2022/https://fusion-live.leviathanstudiosltd.com/events/protein-sciences-in-drug-discovery-elrig/https://fusion-live.leviathanstudiosltd.com/events/vet-health-global-2025/https://fusion-live.leviathanstudiosltd.com/modern-slavery-statement/https://fusion-live.leviathanstudiosltd.com/news-and-insights/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/2-x-production-scientists/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/business-development-manager/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/cld-team-leader/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/commercial-operations-administrator/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/facilities-manager/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/lab-technician/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/laboratory-technician/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/marketing-communications-executive/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/production-scientist/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/protein-characterisation-senior-scientist/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/rd-scientist/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/rd-team-leader/https://fusion-live.leviathanstudiosltd.com/news-and-insights/careers/team-leader-antibody-engineering/https://fusion-live.leviathanstudiosltd.com/news-and-insights/case-studies/https://fusion-live.leviathanstudiosltd.com/news-and-insights/case-studies/a-novel-approach-to-affinity-maturation/https://fusion-live.leviathanstudiosltd.com/news-and-insights/case-studies/better-programmes-through-partnership/https://fusion-live.leviathanstudiosltd.com/news-and-insights/case-studies/humanized-antibody-jf5-detects-aspergillus/https://fusion-live.leviathanstudiosltd.com/news-and-insights/case-studies/potential-biomarkers-for-bladder-and-colon-cancer-2/https://fusion-live.leviathanstudiosltd.com/news-and-insights/case-studies/transparent-scientific-handovers/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/bispecifics-blog/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/fusion-antibodies-quality-by-design/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/harnessing-the-rabbit-antibody-repertoire/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/humanization-much-more-than-a-handle-turning-exercise/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/in-silico-the-future-of-antibody-development/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/keeping-developability-in-view/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/making-your-best-antibody-better/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/overcoming-obstacles-on-the-path-to-the-clinic/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/piloting-successful-transient-protein-expression/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/starting-your-journey-into-manufacturing-choosing-a-cell-line-development-provider/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/stepping-outside-of-the-cdr-to-create-naturalised-libraries-and-humanized-antibodies/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/the-challenges-of-phage-display-for-affinity-maturation/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/therapeutic-antibodies-the-scale-of-the-manufacturing-challenge/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/top-tips-for-humanization-outsourcing/https://fusion-live.leviathanstudiosltd.com/news-and-insights/expert-insights/when-difficult-targets-need-a-different-route/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/200th-humanization/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/ahs-kcc/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/alliance-between-fusion-antibodies-and-nb-health-laboratory/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/appointment-of-chief-executive-officer/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/covid-19-reagents/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/designing-evidence-that-survives-the-next-stage/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/dr-mcgirr-of-fusion-antibodes-named-future-innovator-winner-at-ktp-best-of-the-best-awards-2/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/funding-for-queens-pancreatic-cancer-drug-research-in-collaboration-with-fusion-antibodies/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/fusion-antibodies-and-bizcom-japan-continue-to-strengthen-ties/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/fusion-antibodies-announces-cell-line-development-collaboration-with-celonic/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/fusion-antibodies-announces-collaboration-with-aerpio-therapeutics-for-second-antibody-humanization-project/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/fusion-antibodies-announces-partnership-with-protein-alternatives/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/fusion-antibodies-collaborates-with-queens-university-on-knowledge-transfer-partnership-programme/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/fusion-antibodies-form-strategic-collaboration-with-e2dg-to-provide-end-to-end-service-for-oncology-drug-discovery-companies/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/fusion-antibodies-partner-with-biotickle-to-deliver-antibody-development-services-in-india/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/fusion-antibodies-partner-with-erada-to-develop-ground-breaking-malaria-diagnostic/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/fusion-antibodies-ramps-up-collaboration-success/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/fusion-antibodies-to-collaborate-with-analytics-engines/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/fusion-awarded-platinum-level-innovator-status/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/fusion-eurofins-partnership/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/io-summit-us-2025/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/nicada/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/omicron/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/one-size-fits-all-a-bispecific-antigen-toolkit-for-antibody-discovery-and-screening/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/qub-led-project-moves-to-next-stage-in-multi-million-pound-funding-bid/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/rd-update-mammalian-display-service/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/research-alliance-with-queens-university-belfast/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/scientificadvisorypanel/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/starting-with-the-right-biological-question/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/supporting-indian-biotherapeutic-companies-with-antibody-development/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/translatinglinen/https://fusion-live.leviathanstudiosltd.com/news-and-insights/news/why-is-antibody-humanization-still-important-in-the-21st-century/https://fusion-live.leviathanstudiosltd.com/privacy-policy/https://fusion-live.leviathanstudiosltd.com/services/https://fusion-live.leviathanstudiosltd.com/services/discovery/https://fusion-live.leviathanstudiosltd.com/services/discovery/aiml-ab/https://fusion-live.leviathanstudiosltd.com/services/discovery/antibody-discovery/https://fusion-live.leviathanstudiosltd.com/services/discovery/antigen-design/https://fusion-live.leviathanstudiosltd.com/services/discovery/mouse-hybridoma/https://fusion-live.leviathanstudiosltd.com/services/discovery/optimal-mammalian-display/https://fusion-live.leviathanstudiosltd.com/services/discovery/optiphage/https://fusion-live.leviathanstudiosltd.com/services/discovery/rabbit-b-cell-cloning/https://fusion-live.leviathanstudiosltd.com/services/engineering/https://fusion-live.leviathanstudiosltd.com/services/engineering/adc-design/https://fusion-live.leviathanstudiosltd.com/services/engineering/affinity-maturation/https://fusion-live.leviathanstudiosltd.com/services/engineering/antibody-engineering/https://fusion-live.leviathanstudiosltd.com/services/engineering/bispecific-design/https://fusion-live.leviathanstudiosltd.com/services/engineering/developability/https://fusion-live.leviathanstudiosltd.com/services/engineering/fc-engineering/https://fusion-live.leviathanstudiosltd.com/services/engineering/flame/https://fusion-live.leviathanstudiosltd.com/services/engineering/humanization/https://fusion-live.leviathanstudiosltd.com/services/engineering/reformatting/https://fusion-live.leviathanstudiosltd.com/services/engineering/species-conversion/https://fusion-live.leviathanstudiosltd.com/services/supply/https://fusion-live.leviathanstudiosltd.com/services/supply/antibody-characterization/https://fusion-live.leviathanstudiosltd.com/services/supply/antibody-supply/https://fusion-live.leviathanstudiosltd.com/services/supply/cell-line-development/https://fusion-live.leviathanstudiosltd.com/services/supply/epitope-mapping/https://fusion-live.leviathanstudiosltd.com/services/supply/polyclonal-supply/https://fusion-live.leviathanstudiosltd.com/services/supply/ruo-stable-expression/https://fusion-live.leviathanstudiosltd.com/services/supply/transient-expression/https://fusion-live.leviathanstudiosltd.com/team/https://fusion-live.leviathanstudiosltd.com/team/adrian-kinkaid/https://fusion-live.leviathanstudiosltd.com/team/charlotte-deane/https://fusion-live.leviathanstudiosltd.com/team/colin-walsh/https://fusion-live.leviathanstudiosltd.com/team/james-fair/https://fusion-live.leviathanstudiosltd.com/team/jb-toner/https://fusion-live.leviathanstudiosltd.com/team/matthew-baker/https://fusion-live.leviathanstudiosltd.com/team/nicola-hamilton/https://fusion-live.leviathanstudiosltd.com/team/richard-buick/https://fusion-live.leviathanstudiosltd.com/team/richard-jones/https://fusion-live.leviathanstudiosltd.com/team/simon-douglas/https://fusion-live.leviathanstudiosltd.com/team/stephen-smyth/https://fusion-live.leviathanstudiosltd.com/team/tim-watts/https://fusion-live.leviathanstudiosltd.com/terms-and-conditions/https://fusion-live.leviathanstudiosltd.com/testimonials/